Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Avadel Pharmaceuticals (DE:AWK1)
FRANKFURT:AWK1
RESEARCH TOOLSreports
Holding DE:AWK1?
Track your performance easily
AWK1 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€8.75 - €15.70
Previous Close€15.54
Volume0.00
Average Volume (3M)60.00
Market Cap
€1.53B
Enterprise Value€1.44B
Total Cash (Recent Filing)$105.11M
Total Debt (Recent Filing)$2.62M
Price to Earnings (P/E)―
Beta0.14
Next Earnings
May 06, 2024EPS Estimate
-€0.22Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding90,576,998
10 Day Avg. Volume0
30 Day Avg. Volume60
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)14.74
Price to Sales (P/S)46.32
Price to Cash Flow (P/CF)-13.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue51.33
Enterprise Value/Gross Profit52.93
Enterprise Value/Ebitda-9.81
Forecast
1Y Price Target
€22.11Price Target Upside42.32% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
Avadel Pharmaceuticals News
PremiumCompany Announcements
Avadel Pharmaceuticals Shifts to Nasdaq, Ends ADR Program
Options Prices
Currently, No data available
---
Ownership Overview
15.41% Insiders
5.51% Mutual Funds
0.27% Other Institutional Investors
78.81% Public Companies and
Individual Investors
AWK1 FAQ
What was Avadel Pharmaceuticals’s price range in the past 12 months?
Avadel Pharmaceuticals lowest stock price was €8.75 and its highest was €15.70 in the past 12 months.
What is Avadel Pharmaceuticals’s market cap?
Currently, no data Available
When is Avadel Pharmaceuticals’s upcoming earnings report date?
Avadel Pharmaceuticals’s upcoming earnings report date is May 06, 2024 which is 190 days ago.
How were Avadel Pharmaceuticals’s earnings last quarter?
Avadel Pharmaceuticals released its earnings results on Mar 04, 2024. The company reported -€0.301 earnings per share for the quarter, missing the consensus estimate of -€0.265 by -€0.037.
Is Avadel Pharmaceuticals overvalued?
According to Wall Street analysts Avadel Pharmaceuticals’s price is currently Undervalued.
Does Avadel Pharmaceuticals pay dividends?
Avadel Pharmaceuticals does not currently pay dividends.
What is Avadel Pharmaceuticals’s EPS estimate?
Avadel Pharmaceuticals’s EPS estimate is -€0.22.
How many shares outstanding does Avadel Pharmaceuticals have?
Avadel Pharmaceuticals has 90,576,996 shares outstanding.
What happened to Avadel Pharmaceuticals’s price movement after its last earnings report?
Avadel Pharmaceuticals reported an EPS of -€0.301 in its last earnings report, missing expectations of -€0.265. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Avadel Pharmaceuticals?
Among the largest hedge funds holding Avadel Pharmaceuticals’s share is Woodline Partners LP. It holds Avadel Pharmaceuticals’s shares valued at 26M.
---
Avadel Pharmaceuticals Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€22.11 (42.32% Upside)
€22.11 (42.32% Upside)
Blogger Sentiment
Bullish
DE:AWK1 Sentiment 100%
Sector Average 70%
Sector Average 70%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
82.54%
12-Months-Change
Fundamentals
Return on Equity
-481.35%
Trailing 12-Months
Asset Growth
27.92%
Trailing 12-Months
Company Description
Avadel Pharmaceuticals
Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. It offers Bloxiverz, Vazculep, and Akovaz. The company was founded on December 1, 2015 and is headquartered in Dublin, Ireland.
---
AWK1 Stock 12 Month Forecast
Average Price Target
€22.11
▲(42.32% Upside)
Technical Analysis
Avadel Pharmaceuticals
―
Heron Therapeutics
―
Karyopharm Therapeutics
―
Innoviva
―
Acorda Therapeutics
―
Best Analysts Covering AWK1
1 Year
1 Year Success Rate
18/23 ratings generated profit
1 Year Average Return
+74.61%
reiterated a buy rating 8 months ago
Copying Ami Fadia's trades and holding each position for 1 Year would result in 78.26% of your transactions generating a profit, with an average return of +74.61% per trade.
---